1. Prednisone (PDN)/Sirolimus (SRL) Compared to PDN/SRL/Calcineurin Inhibitor (CNI) as Treatment for Chronic Graft-Versus-Host-Disease (cGVHD): A Randomized Phase II Study from the Blood and Marrow Transplant Clinical Trials Network 
Paul A. Carpenter, MD, Brent R. Logan, PhD, Stephanie J. Lee, MD, MPH, Daniel J. Weisdorf, MD, Laura Johnston, MD, Luciano J. Costa, MD, PhD, Carrie L. Kitko, MD, Javier Bolaños-Meade, MD, Amin M. Alousi, MD, Mary M. Horowitz, MD, MS, Sunil Abhyankar, MD, Edmund K. Waller, MD, PhD, Adam Mendizabal, PhD, Yanli Wang, Aleksandr Lazaryan, MD MPH PhD, Shelly L. Carter, ScD, Eneida R. Nemecek, MD, Steven Z. Pavletic, MD, Corey S. Cutler, MD, MPH, Mukta Arora, MD, MS 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S50-S52 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Steroid Dose
Biology of Blood and Marrow Transplantation  , S50-S52DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2A Failure-Free Survival for PDN/SRL/CN1 Arm
Biology of Blood and Marrow Transplantation  , S50-S52DOI: ( /j.bbmt )
Copyright © Terms and Conditions

4. Figure 2B Failure-Free Survival for PDN/SRL Arm
Biology of Blood and Marrow Transplantation  , S50-S52DOI: ( /j.bbmt )
Copyright © Terms and Conditions